NextCell Pharma has formed a subsidiary company, QVance, specializing in quality control analytics. QVance, based in Huddinge, will specialize in quality analyses for advanced therapeutic companies, including NextCell, in the
Biotech
The funds will be used to support development of Asgard’s lead program AT-108 to IND-readiness by 2026, expand and reinforce its research and development team, and fuel new reprogramming modalities
Anocca and EmendoBio have announced a non-exclusive licensing agreement for the use of EmendoBio’s novel OMNI-A4 nuclease to accelerate the manufacture and development of Anocca’s deep pipeline of TCR-T cell
The company will establish a new laboratory in Uppsala, Sweden, during the spring. The lab will be well-equipped for vaccine development, with instrumentation that enables the company to develop more
Via the agreement, the enhancing effect of the iTANK-technology will be evaluated in a novel T-cell receptor therapy targeting skin cancer and lung cancer. As per the agreement, Elicera Therapeutics
The European Innovation Council (EIC) has announced that Gedea Biotech has been selected for the EUR 2.5 million EIC Accelerator grant for the continued development and commercialization of pHyph, an
The company’s strategic changes include a staff reduction, Cellaviva becoming a wholly owned subsidiary and the GMP facility will have new sources of revenue. NextCell develops the cell therapy drug
The European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to Aurealis Therapeutics’ lead product candidate AUP-16 for the treatment of non-healing Diabetic Foot Ulcers (nhDFU). “With the PRIME
Ultimovacs has announced that the European Medicines Agency (EMA) has issued a positive opinion on the company’s application for Orphan Drug Designation (ODD) for its therapeutic cancer vaccine UV1 for
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Diamyd that is being investigated to improve glycemic control in recently diagnosed stage 3 Type 1 Diabetes